Ionis Pharmaceuticals licensed Zilganersen to Recordati, which is now undergoing international regulatory filings and FDA review.
1 report, 1 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ionis Pharmaceuticals licensed Zilganersen to Recordati, which is now undergoing international regulatory filings and FDA review.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Recordati
Italian pharmaceutical company
Nothing else this week.
-
Ionis Pharmaceuticals
American pharmaceutical company